BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 38702773)

  • 21. Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer.
    Friess H; Ding J; Kleeff J; Fenkell L; Rosinski JA; Guweidhi A; Reidhaar-Olson JF; Korc M; Hammer J; Büchler MW
    Cell Mol Life Sci; 2003 Jun; 60(6):1180-99. PubMed ID: 12861384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell analyses reveal evolution mimicry during the specification of breast cancer subtype.
    Gao ZJ; Fang H; Sun S; Liu SQ; Fang Z; Liu Z; Li B; Wang P; Sun SR; Meng XY; Wu Q; Chen CS
    Theranostics; 2024; 14(8):3104-3126. PubMed ID: 38855191
    [No Abstract]   [Full Text] [Related]  

  • 23. Integrating single-cell and spatial analysis reveals MUC1-mediated cellular crosstalk in mucinous colorectal adenocarcinoma.
    Zhou H; Shen Y; Zheng G; Zhang B; Wang A; Zhang J; Hu H; Lin J; Liu S; Luan X; Zhang W
    Clin Transl Med; 2024 May; 14(5):e1701. PubMed ID: 38778448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma.
    Lin J; Liu P; Sun K; Jiang L; Liu Y; Huang Y; Liu J; Shi M; Zhang J; Wang T; Shen B
    Cancer Cell Int; 2024 May; 24(1):177. PubMed ID: 38773440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer.
    Yoo HB; Moon JW; Kim HR; Lee HS; Miyabayashi K; Park CH; Ge S; Zhang A; Tae YK; Sub Y; Park HW; Gee HY; Notta F; Tuveson DA; Bang S; Kim MY; Roe JS
    Gastroenterology; 2023 Jul; 165(1):133-148.e17. PubMed ID: 36907523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-cell RNA sequencing reveals the process of CA19-9 production and dynamics of the immune microenvironment between CA19-9 (+) and CA19-9 (-) PDAC.
    Zhang D; Cui F; Zheng K; Li W; Liu Y; Wu C; Peng L; Yang Z; Chen Q; Xia C; Li S; Jin Z; Xu X; Jin G; Li Z; Huang H
    Chin Med J (Engl); 2024 May; ():. PubMed ID: 38816396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer.
    Langerud J; Eilertsen IA; Moosavi SH; Klokkerud SMK; Reims HM; Backe IF; Hektoen M; Sjo OH; Jeanmougin M; Tejpar S; Nesbakken A; Lothe RA; Sveen A
    Nat Commun; 2024 May; 15(1):4342. PubMed ID: 38773143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma.
    Desai A; Xiao AH; Choi D; Toruner MD; Walden D; Halfdanarson TR; Alberts S; McWilliams RR; Mahipal A; Ahn D; Babiker H; Stybayeva G; Revzin A; Kizilbash S; Adjei A; Bekaii-Saab T; Mansfield AS; Carr RM; Ma WW
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer.
    Sussman J; Kim NY; Kemp SB; Traum D; Katsuda T; Kahn BM; Xu J; Kim IK; Eskandarian C; Delman D; Beatty GL; Kaestner KH; Simpson AL; Stanger BZ
    Cancer Res; 2024 May; ():. PubMed ID: 38695869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatial genomics maps the structure, nature and evolution of cancer clones.
    Lomakin A; Svedlund J; Strell C; Gataric M; Shmatko A; Rukhovich G; Park JS; Ju YS; Dentro S; Kleshchevnikov V; Vaskivskyi V; Li T; Bayraktar OA; Pinder S; Richardson AL; Santagata S; Campbell PJ; Russnes H; Gerstung M; Nilsson M; Yates LR
    Nature; 2022 Nov; 611(7936):594-602. PubMed ID: 36352222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell and single-nucleus RNA-sequencing from paired normal-adenocarcinoma lung samples provide both common and discordant biological insights.
    Renaut S; Armero VS; Boudreau DK; Gaudreault N; Desmeules P; Thériault S; Mathieu P; Joubert P; Bossé Y
    PLoS Genet; 2024 May; 20(5):e1011301. PubMed ID: 38814983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer.
    Fu Y; Tao J; Gu Y; Liu Y; Qiu J; Su D; Wang R; Luo W; Liu T; Zhang F; Zhang T; Zhao Y
    NPJ Precis Oncol; 2024 May; 8(1):109. PubMed ID: 38769374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compartment resolved proteomics reveals a dynamic matrisome in a biomechanically driven model of pancreatic ductal adenocarcinoma.
    Barrett AS; Maller O; Pickup MW; Weaver VM; Hansen KC
    J Immunol Regen Med; 2018 Mar; 1():67-75. PubMed ID: 36908331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting tumor transcriptional heterogeneity from single-cell RNA-seq data by generalized binary covariance decomposition.
    Liu Y; Carbonetto P; Willwerscheid J; Oakes SA; Macleod KF; Stephens M
    bioRxiv; 2024 May; ():. PubMed ID: 37645713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immune response to a fungus in pancreatic cancer samples.
    Brayer KJ; Hanson JA; Cingam S; Martinez C; Ness SA; Rabinowitz I
    bioRxiv; 2023 Mar; ():. PubMed ID: 37034706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing approach.
    Gál E; Parvaneh S; Miklós V; Hegyi P; Kemény L; Veréb Z; Venglovecz V
    J Biotechnol; 2024 May; 391():20-32. PubMed ID: 38815810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer.
    Grausenburger R; Herek P; Shariat SF; Englinger B
    Curr Opin Urol; 2024 Jul; 34(4):236-243. PubMed ID: 38650456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients.
    Huerta M; Martín-Arana J; Gimeno-Valiente F; Carbonell-Asins JA; García-Micó B; Martínez-Castedo B; Robledo-Yagüe F; Camblor DG; Fleitas T; García Bartolomé M; Alfaro-Cervelló C; Garcés-Albir M; Dorcaratto D; Muñoz-Forner E; Seguí V; Mora-Oliver I; Gambardella V; Roselló S; Sabater L; Roda D; Cervantes A; Tarazona N
    Transl Res; 2024 May; 271():105-115. PubMed ID: 38782356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer.
    Acharjee A; Okyere D; Nath D; Nagar S; Gkoutos GV
    Heliyon; 2024 May; 10(10):e31437. PubMed ID: 38803850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDAC heterogeneity resolved spatially at the single-cell level: new biological answers, new questions on optimal translation
    Felipe I; Real FX
    J Pathol; 2024 Jun; ():. PubMed ID: 38828491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.